Scholarlink

Introduction <p>Fatigue is a prevalent and late effect among childhood cancer survivors (CCSs). Few large studies have comprehensively evaluated its prevalence and determinants. Identifying risk factors for fatigue and severe fatigue (SF) is crucial to improving survivorship care. This study assessed the prevalence of fatigue and SF, as well as demographic, clinical, and treatment-related predictors in the French Childhood Cancer Survivor Study (FCCSS).</p> Methods <p>This cross-sectional analysis included adult 5-year CCSs diagnosed before age 21 (1946–2000) in the FCCSS cohort. Fatigue was measured using the French Multidimensional Fatigue Inventory (MFI-20); SF was defined as a total score &gt; 60. Associations with sex, age, cancer type, treatment, and social deprivation were estimated using multivariable regressions. Analyses were stratified by central nervous system (CNS) <i>vs.</i> non-CNS tumors and compared to general population norms.</p> Results <p>Among 3170 CCSs, fatigue scores exceeded population norms from age 30, with women affected earlier and more severely. General (10.0 ± 4.2) and physical fatigue (9.6 ± 4.2) were the most pronounced dimensions, increasing with age and peaking at ≥ 50&#xa0;years. Higher fatigue scores were independently associated with female sex, obesity, older age, and CNS tumor history. SF affected 16% of CCSs, more frequently in women (<i>OR</i> = 1.30), obese survivors (<i>OR</i> = 2.40), CNS tumor survivors (<i>OR</i> = 3.27), hematologic tumor survivors (<i>OR</i> = 1.46), and radiotherapy exposure (<i>OR</i> = 1.46).</p> Conclusion <p>Fatigue remains a common, persistent late effect in CCSs. Female sex, older age, CNS tumors, and radiotherapy were strong predictors, underscoring the needs for targeted screening and long-term management.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Fatigue among adult survivors of childhood cancer: findings from the French Childhood Cancer Survivor Study

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年3月14日

查看全文
  • Médéa Locquet,
  • Duc Hoan Vu,
  • Rodrigue Allodji,
  • Neige Journy,
  • Chiraz El-Fayech,
  • Charlotte Demoor-Goldschmidt,
  • Laura Lenez,
  • Cécile Thomas-Teinturier,
  • Stéphanie Bolle,
  • Nadia Haddy,
  • Giao Vu-Bezin,
  • Agnès Dumas,
  • David Rajaonera,
  • Nicolas Bougas,
  • Jacques Grill,
  • Christelle Dufour,
  • Hélène Pacquement,
  • Ibrahima Diallo,
  • Jean Bernard Le-Provost,
  • François Doz,
  • Brice Fresneau,
  • Florent De Vathaire

摘要

Introduction

Fatigue is a prevalent and late effect among childhood cancer survivors (CCSs). Few large studies have comprehensively evaluated its prevalence and determinants. Identifying risk factors for fatigue and severe fatigue (SF) is crucial to improving survivorship care. This study assessed the prevalence of fatigue and SF, as well as demographic, clinical, and treatment-related predictors in the French Childhood Cancer Survivor Study (FCCSS).

Methods

This cross-sectional analysis included adult 5-year CCSs diagnosed before age 21 (1946–2000) in the FCCSS cohort. Fatigue was measured using the French Multidimensional Fatigue Inventory (MFI-20); SF was defined as a total score > 60. Associations with sex, age, cancer type, treatment, and social deprivation were estimated using multivariable regressions. Analyses were stratified by central nervous system (CNS) vs. non-CNS tumors and compared to general population norms.

Results

Among 3170 CCSs, fatigue scores exceeded population norms from age 30, with women affected earlier and more severely. General (10.0 ± 4.2) and physical fatigue (9.6 ± 4.2) were the most pronounced dimensions, increasing with age and peaking at ≥ 50 years. Higher fatigue scores were independently associated with female sex, obesity, older age, and CNS tumor history. SF affected 16% of CCSs, more frequently in women (OR = 1.30), obese survivors (OR = 2.40), CNS tumor survivors (OR = 3.27), hematologic tumor survivors (OR = 1.46), and radiotherapy exposure (OR = 1.46).

Conclusion

Fatigue remains a common, persistent late effect in CCSs. Female sex, older age, CNS tumors, and radiotherapy were strong predictors, underscoring the needs for targeted screening and long-term management.